
<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>World Pharma News / Published News / Corporate</title>
<link>http://www.worldpharmanews.net</link>
<description>World Pharma News .net - Web 2.0 pharmaceutical news portal  votes</description>
<pubDate>Thu, 27 Nov 2008 00:04:42 EET</pubDate>
<language>en</language>
<item>
<title><![CDATA[AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva]]></title>
<link>http://www.worldpharmanews.net/Corporate/AstraZeneca_Settles_US_Pulmicort_Respules_Patent_Litigation_with_Teva/</link>
<comments>http://www.worldpharmanews.net/Corporate/AstraZeneca_Settles_US_Pulmicort_Respules_Patent_Litigation_with_Teva/</comments>
<pubDate>Thu, 27 Nov 2008 00:04:42 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/AstraZeneca_Settles_US_Pulmicort_Respules_Patent_Litigation_with_Teva/</guid>
<description><![CDATA[AstraZeneca has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GSK and Neptunus form joint venture for the co-development of flu vaccines]]></title>
<link>http://www.worldpharmanews.net/Corporate/GSK_and_Neptunus_form_joint_venture_for_the_co-development_of_flu_vaccines/</link>
<comments>http://www.worldpharmanews.net/Corporate/GSK_and_Neptunus_form_joint_venture_for_the_co-development_of_flu_vaccines/</comments>
<pubDate>Tue, 25 Nov 2008 00:06:57 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GSK_and_Neptunus_form_joint_venture_for_the_co-development_of_flu_vaccines/</guid>
<description><![CDATA[GlaxoSmithKline (GSK) has signed an exclusive Cooperation Agreement with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (NIBT) as a preliminary step in forming a Joint Venture (JV) between the tw<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Outsourcing Pharmaceutical R&amp;D : Bio Job Blog]]></title>
<link>http://www.worldpharmanews.net/Corporate/Outsourcing_Pharmaceutical_RD__Bio_Job_Blog/</link>
<comments>http://www.worldpharmanews.net/Corporate/Outsourcing_Pharmaceutical_RD__Bio_Job_Blog/</comments>
<pubDate>Sun, 23 Nov 2008 01:14:22 EET</pubDate>
<dc:creator>cliffmz</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Outsourcing_Pharmaceutical_RD__Bio_Job_Blog/</guid>
<description><![CDATA[As you all know by now, American pharmaceutical companies have been intermittently laying off thousands of employees for the past two years or so. Many of the employees who have lost their jobs are R<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation]]></title>
<link>http://www.worldpharmanews.net/Corporate/AstraZeneca_granted_Temporary_Restraining_Order_in_PULMICORT_RESPULES_patent_litigation/</link>
<comments>http://www.worldpharmanews.net/Corporate/AstraZeneca_granted_Temporary_Restraining_Order_in_PULMICORT_RESPULES_patent_litigation/</comments>
<pubDate>Fri, 21 Nov 2008 00:07:26 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/AstraZeneca_granted_Temporary_Restraining_Order_in_PULMICORT_RESPULES_patent_litigation/</guid>
<description><![CDATA[On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation sus<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer and UCB Announce Formation of New Company Cyclofluidic to Accelerate Drug Discovery Process]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_and_UCB_Announce_Formation_of_New_Company_Cyclofluidic_to_Accelerate_Drug_Discovery_Process/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_and_UCB_Announce_Formation_of_New_Company_Cyclofluidic_to_Accelerate_Drug_Discovery_Process/</comments>
<pubDate>Wed, 22 Oct 2008 00:06:33 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_and_UCB_Announce_Formation_of_New_Company_Cyclofluidic_to_Accelerate_Drug_Discovery_Process/</guid>
<description><![CDATA[Pfizer Ltd (NYSE:PFE) (LSE:PFZ) and UCB have announced the formation of Cyclofluidic, a breakthrough technology company established with the aim of significantly accelerating the drug discovery proce<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_Reaches_Agreements_in_Principle_to_Resolve_Litigation_Involving_Its_NSAID_Pain_Medications/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_Reaches_Agreements_in_Principle_to_Resolve_Litigation_Involving_Its_NSAID_Pain_Medications/</comments>
<pubDate>Sun, 19 Oct 2008 12:17:13 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_Reaches_Agreements_in_Principle_to_Resolve_Litigation_Involving_Its_NSAID_Pain_Medications/</guid>
<description><![CDATA[Pfizer Inc announced today that it has reached agreements in principle to resolve substantially all of the personal injury cases, consumer fraud cases and state attorneys general claims involving its<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[European Journalists' Prize 2008 announced by Bayer HealthCare]]></title>
<link>http://www.worldpharmanews.net/Corporate/European_Journalists_Prize_2008_announced_by_Bayer_HealthCare/</link>
<comments>http://www.worldpharmanews.net/Corporate/European_Journalists_Prize_2008_announced_by_Bayer_HealthCare/</comments>
<pubDate>Wed, 15 Oct 2008 00:57:58 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/European_Journalists_Prize_2008_announced_by_Bayer_HealthCare/</guid>
<description><![CDATA[Scrupulously researched articles dealing with a topic from the worlds of medicine or health care - articles written in a critical, comprehensible, yet objective manner - have an excellent chance of w<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Genzyme Recognized by Scientists as a Top Employer]]></title>
<link>http://www.worldpharmanews.net/Corporate/Genzyme_Recognized_by_Scientists_as_a_Top_Employer/</link>
<comments>http://www.worldpharmanews.net/Corporate/Genzyme_Recognized_by_Scientists_as_a_Top_Employer/</comments>
<pubDate>Sat, 11 Oct 2008 00:11:54 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Genzyme_Recognized_by_Scientists_as_a_Top_Employer/</guid>
<description><![CDATA[Genzyme Corporation (Nasdaq: GENZ) has announced that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. This ye<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme]]></title>
<link>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_signs_a_license_agreement_with_Evec_Inc-_for_its_fully-human_antibody_programme/</link>
<comments>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_signs_a_license_agreement_with_Evec_Inc-_for_its_fully-human_antibody_programme/</comments>
<pubDate>Sat, 04 Oct 2008 01:05:44 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_signs_a_license_agreement_with_Evec_Inc-_for_its_fully-human_antibody_programme/</guid>
<description><![CDATA[Boehringer Ingelheim has signed a licence agreement with Evec, Inc., Japan, for one of its fully-human therapeutic antibody programmes. Based on the agreement, Boehringer Ingelheim will obtain worldw<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Shire Limited has changed its name to Shire plc]]></title>
<link>http://www.worldpharmanews.net/Corporate/Shire_Limited_has_changed_its_name_to_Shire_plc/</link>
<comments>http://www.worldpharmanews.net/Corporate/Shire_Limited_has_changed_its_name_to_Shire_plc/</comments>
<pubDate>Thu, 02 Oct 2008 01:02:59 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Shire_Limited_has_changed_its_name_to_Shire_plc/</guid>
<description><![CDATA[Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that following the approval by shareholders at the Annual General Meeting on September 24, 2008, the<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer starts new research cooperation in Asia]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bayer_starts_new_research_cooperation_in_Asia/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bayer_starts_new_research_cooperation_in_Asia/</comments>
<pubDate>Wed, 01 Oct 2008 01:05:47 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bayer_starts_new_research_cooperation_in_Asia/</guid>
<description><![CDATA[Bayer Schering Pharma and the National University of Singapore (NUS) have agreed to cooperate in the field of pre-clinical cancer research. The initial collaboration with the NUS will focus on three <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[US Court Denies Teva's Motion For Summary Judgment In Pulmicort Respules Patent Litigation]]></title>
<link>http://www.worldpharmanews.net/Corporate/US_Court_Denies_Tevas_Motion_For_Summary_Judgment_In_Pulmicort_Respules_Patent_Litigation/</link>
<comments>http://www.worldpharmanews.net/Corporate/US_Court_Denies_Tevas_Motion_For_Summary_Judgment_In_Pulmicort_Respules_Patent_Litigation/</comments>
<pubDate>Fri, 26 Sep 2008 01:04:08 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/US_Court_Denies_Tevas_Motion_For_Summary_Judgment_In_Pulmicort_Respules_Patent_Litigation/</guid>
<description><![CDATA[AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES (budesonide inhalatio<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Nycomed optimises its European manufacturing network]]></title>
<link>http://www.worldpharmanews.net/Corporate/Nycomed_optimises_its_European_manufacturing_network/</link>
<comments>http://www.worldpharmanews.net/Corporate/Nycomed_optimises_its_European_manufacturing_network/</comments>
<pubDate>Thu, 25 Sep 2008 01:03:48 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Nycomed_optimises_its_European_manufacturing_network/</guid>
<description><![CDATA[Nycomed has announced a new strategy for its European manufacturing network. The company will focus its European production at five dedicated centres of competence and five facilities for regional su<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[DHL COLDCHAIN offers fast, reliable and flexible solutions designed for the Life Science Industry]]></title>
<link>http://www.worldpharmanews.net/Corporate/DHL_COLDCHAIN_offers_fast_reliable_and_flexible_solutions_designed_for_the_Life_Science_Industry/</link>
<comments>http://www.worldpharmanews.net/Corporate/DHL_COLDCHAIN_offers_fast_reliable_and_flexible_solutions_designed_for_the_Life_Science_Industry/</comments>
<pubDate>Wed, 17 Sep 2008 01:03:22 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/DHL_COLDCHAIN_offers_fast_reliable_and_flexible_solutions_designed_for_the_Life_Science_Industry/</guid>
<description><![CDATA[The life science industry increasingly demands for Europe-wide transport solutions which are able to guarantee product integrity. Being able to offer this, strengthens a global market position. Thus,<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer Intensifies Research in Early Diagnosis of Alzheimer's Disease]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bayer_Intensifies_Research_in_Early_Diagnosis_of_Alzheimers_Disease/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bayer_Intensifies_Research_in_Early_Diagnosis_of_Alzheimers_Disease/</comments>
<pubDate>Fri, 12 Sep 2008 11:57:58 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bayer_Intensifies_Research_in_Early_Diagnosis_of_Alzheimers_Disease/</guid>
<description><![CDATA[Bayer Schering Pharma and the University of Nagasaki (Japan) have signed a licensing agreement on the use of novel substances for molecular imaging. Being used as tracers in Positron Emission Tomogra<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania]]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_Fund_to_Build_First_Pediatric_HIVAIDS_Clinic_in_Tanzania/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_Fund_to_Build_First_Pediatric_HIVAIDS_Clinic_in_Tanzania/</comments>
<pubDate>Mon, 01 Sep 2008 01:01:48 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_Fund_to_Build_First_Pediatric_HIVAIDS_Clinic_in_Tanzania/</guid>
<description><![CDATA[The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other partners today at a U.S. President's Emergency Plan for AIDS Relief <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement]]></title>
<link>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_Valeant_Pharmaceuticals_announce_worldwide_collaboration_agreement/</link>
<comments>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_Valeant_Pharmaceuticals_announce_worldwide_collaboration_agreement/</comments>
<pubDate>Sat, 30 Aug 2008 01:07:11 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_Valeant_Pharmaceuticals_announce_worldwide_collaboration_agreement/</guid>
<description><![CDATA[GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug retigabin<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Brings complementary capabilities in India to address patient populations most at risk]]></title>
<link>http://www.worldpharmanews.net/Corporate/Brings_complementary_capabilities_in_India_to_address_patient_populations_most_at_risk/</link>
<comments>http://www.worldpharmanews.net/Corporate/Brings_complementary_capabilities_in_India_to_address_patient_populations_most_at_risk/</comments>
<pubDate>Wed, 27 Aug 2008 11:28:51 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Brings_complementary_capabilities_in_India_to_address_patient_populations_most_at_risk/</guid>
<description><![CDATA[Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&amp;D) organization dedicated to reducing the<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novo Nordisk joins the Call to Action for gender equality]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_joins_the_Call_to_Action_for_gender_equality/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_joins_the_Call_to_Action_for_gender_equality/</comments>
<pubDate>Fri, 22 Aug 2008 01:04:03 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_joins_the_Call_to_Action_for_gender_equality/</guid>
<description><![CDATA[Yesterday, the Danish Minister for Development Cooperation Ms Ulla Tørnæs handed over a torch to Executive Vice President Lise Kingo, Novo Nordisk, at a ceremony in Copenhagen. With the torch Ms Tørn<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[DAIICHI SANKYO continues its expansion in Germany and Europe]]></title>
<link>http://www.worldpharmanews.net/Corporate/DAIICHI_SANKYO_continues_its_expansion_in_Germany_and_Europe/</link>
<comments>http://www.worldpharmanews.net/Corporate/DAIICHI_SANKYO_continues_its_expansion_in_Germany_and_Europe/</comments>
<pubDate>Thu, 21 Aug 2008 21:02:38 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/DAIICHI_SANKYO_continues_its_expansion_in_Germany_and_Europe/</guid>
<description><![CDATA[At the beginning of August, DAIICHI SANKYO DEUTSCHLAND GmbH is planning to take over most of the sales force for primary-care physicians in Germany used by Merck Pharma GmbH and to integrate them int<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_and_PDL_BioPharma_Enter_Global_Alliance/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_and_PDL_BioPharma_Enter_Global_Alliance/</comments>
<pubDate>Thu, 21 Aug 2008 01:03:46 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_and_PDL_BioPharma_Enter_Global_Alliance/</guid>
<description><![CDATA[Bristol-Myers Squibb Company (NYSE: BMY) and PDL BioPharma, Inc. (NASDAQ: PDLI) announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzum<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[IAFF Launches Smoking Cessation Campaign with Pfizer]]></title>
<link>http://www.worldpharmanews.net/Corporate/IAFF_Launches_Smoking_Cessation_Campaign_with_Pfizer/</link>
<comments>http://www.worldpharmanews.net/Corporate/IAFF_Launches_Smoking_Cessation_Campaign_with_Pfizer/</comments>
<pubDate>Wed, 13 Aug 2008 01:16:23 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/IAFF_Launches_Smoking_Cessation_Campaign_with_Pfizer/</guid>
<description><![CDATA[The International Association of Fire Fighters has announced the launch of a new initiative to help fire fighters, family members and friends to quit smoking cigarettes. &quot;Our goal is to help make th<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novo Nordisk employee suspended after being charged with insider trading]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_employee_suspended_after_being_charged_with_insider_trading/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_employee_suspended_after_being_charged_with_insider_trading/</comments>
<pubDate>Tue, 05 Aug 2008 01:10:44 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_employee_suspended_after_being_charged_with_insider_trading/</guid>
<description><![CDATA[Novo Nordisk has suspended one of its employees after the employee yesterday was charged by the Danish Public Prosecutor for Serious Economic Crime with unlawful insider trading in the company's sha<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration]]></title>
<link>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_the_Harvard_Stem_Cell_Institute_announce_a_unique_collaboration/</link>
<comments>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_the_Harvard_Stem_Cell_Institute_announce_a_unique_collaboration/</comments>
<pubDate>Wed, 30 Jul 2008 01:06:32 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_and_the_Harvard_Stem_Cell_Institute_announce_a_unique_collaboration/</guid>
<description><![CDATA[GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell sc<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Boehringer Ingelheim FENS Award for exceptional research in neuroscience]]></title>
<link>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_FENS_Award_for_exceptional_research_in_neuroscience/</link>
<comments>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_FENS_Award_for_exceptional_research_in_neuroscience/</comments>
<pubDate>Thu, 17 Jul 2008 01:10:20 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_FENS_Award_for_exceptional_research_in_neuroscience/</guid>
<description><![CDATA[The 2008 Boehringer Ingelheim FENS Research Award goes to Pascal Fries, MD, PhD, from the F.C. Donders Centre for Cognitive Neuroimaging in Nijmegen, The Netherlands. At the Congress of the Federatio<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novartis_Pharmaceuticals_Corporation_to_Appeal_Judgment_in_Alabama_Pricing_Case/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novartis_Pharmaceuticals_Corporation_to_Appeal_Judgment_in_Alabama_Pricing_Case/</comments>
<pubDate>Mon, 07 Jul 2008 12:33:33 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novartis_Pharmaceuticals_Corporation_to_Appeal_Judgment_in_Alabama_Pricing_Case/</guid>
<description><![CDATA[Novartis Pharmaceuticals Corporation (NPC) announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Summary Judgment Granted for SEROQUEL Patent Litigation in the US]]></title>
<link>http://www.worldpharmanews.net/Corporate/Summary_Judgment_Granted_for_SEROQUEL_Patent_Litigation_in_the_US/</link>
<comments>http://www.worldpharmanews.net/Corporate/Summary_Judgment_Granted_for_SEROQUEL_Patent_Litigation_in_the_US/</comments>
<pubDate>Fri, 04 Jul 2008 13:30:54 EEST</pubDate>
<dc:creator>god</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Summary_Judgment_Granted_for_SEROQUEL_Patent_Litigation_in_the_US/</guid>
<description><![CDATA[AstraZeneca announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceuti<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novartis_Institute_for_Tropical_Diseases_and_Global_Alliance_for_TB_Drug_Development/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novartis_Institute_for_Tropical_Diseases_and_Global_Alliance_for_TB_Drug_Development/</comments>
<pubDate>Sat, 28 Jun 2008 12:20:59 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novartis_Institute_for_Tropical_Diseases_and_Global_Alliance_for_TB_Drug_Development/</guid>
<description><![CDATA[The Novartis Institute for Tropical Diseases (NITD) and the Global Alliance for TB Drug Development (TB Alliance) announced a five-year research collaboration designed to yield new medicines for TB, <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott and Partnership for a Drug-Free America Launch 'Not In My House']]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_and_Partnership_for_a_Drug-Free_America_Launch_Not_In_My_House/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_and_Partnership_for_a_Drug-Free_America_Launch_Not_In_My_House/</comments>
<pubDate>Thu, 26 Jun 2008 01:17:20 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_and_Partnership_for_a_Drug-Free_America_Launch_Not_In_My_House/</guid>
<description><![CDATA[A house is the one place where a family should feel safe and secure, yet it is here that teens are prone to get prescription drugs to misuse and abuse. To help prevent teen prescription drug misuse a<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer concludes supply and licensing agreements for Yasmin and YAZ with Barr for the United States]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bayer_concludes_supply_and_licensing_agreements_for_Yasmin%AE_and_YAZ%AE_with_Barr_for_the_United_States/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bayer_concludes_supply_and_licensing_agreements_for_Yasmin%AE_and_YAZ%AE_with_Barr_for_the_United_States/</comments>
<pubDate>Wed, 25 Jun 2008 01:29:39 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bayer_concludes_supply_and_licensing_agreements_for_Yasmin%AE_and_YAZ%AE_with_Barr_for_the_United_States/</guid>
<description><![CDATA[Bayer and Barr Laboratories Inc. today signed supply and licensing agreements for Yasmin® and YAZ® for the United States. Bayer will supply U.S. generics manufacturer Barr, starting July 1, 2008 at t<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_and_Ranbaxy_Settle_Lipitor_Patent_Litigation_Worldwide/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_and_Ranbaxy_Settle_Lipitor_Patent_Litigation_Worldwide/</comments>
<pubDate>Sat, 21 Jun 2008 11:04:57 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_and_Ranbaxy_Settle_Lipitor_Patent_Litigation_Worldwide/</guid>
<description><![CDATA[Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigat<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration]]></title>
<link>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Columbia_University_Medical_Center_Sign_Strategic_Research_Collaboration/</link>
<comments>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Columbia_University_Medical_Center_Sign_Strategic_Research_Collaboration/</comments>
<pubDate>Thu, 19 Jun 2008 01:24:56 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Columbia_University_Medical_Center_Sign_Strategic_Research_Collaboration/</guid>
<description><![CDATA[AstraZeneca and Columbia University Medical Center in New York announced that they have entered into a strategic research collaboration in metabolic related diseases, to develop novel therapeutics pr<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer Celebrates 5 Years of High-Impact Corporate Volunteer Missions]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_Celebrates_5_Years_of_High-Impact_Corporate_Volunteer_Missions/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_Celebrates_5_Years_of_High-Impact_Corporate_Volunteer_Missions/</comments>
<pubDate>Tue, 17 Jun 2008 10:20:09 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_Celebrates_5_Years_of_High-Impact_Corporate_Volunteer_Missions/</guid>
<description><![CDATA[This summer, Maria Machado, a supply chain expert from Brazil, will make an extended visit to Africa - unlike any trip she's taken before. Maria and 15 of her colleagues at Pfizer, Inc. are part of <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Nycomed sells oncology programs to 4SC]]></title>
<link>http://www.worldpharmanews.net/Corporate/Nycomed_sells_oncology_programs_to_4SC/</link>
<comments>http://www.worldpharmanews.net/Corporate/Nycomed_sells_oncology_programs_to_4SC/</comments>
<pubDate>Fri, 06 Jun 2008 09:52:36 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Nycomed_sells_oncology_programs_to_4SC/</guid>
<description><![CDATA[Nycomed agreed with 4SC on the sale of a major part of Nycomed's R&amp;D projects in the field of oncology. Eight projects in the preclinical and first clinical stage will be transferred to 4SC. The agr<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bayer_HealthCare_Commits_US-Dollar_2-5_Million_in_Funding_to_Advance_Global_Hemophilia_Research/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bayer_HealthCare_Commits_US-Dollar_2-5_Million_in_Funding_to_Advance_Global_Hemophilia_Research/</comments>
<pubDate>Thu, 05 Jun 2008 10:57:49 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bayer_HealthCare_Commits_US-Dollar_2-5_Million_in_Funding_to_Advance_Global_Hemophilia_Research/</guid>
<description><![CDATA[Bayer HealthCare announced that it is awarding more than US-Dollar 2.5 million in funding through its Bayer Hemophilia Awards Program (BHAP). 21 individuals from 12 countries will be supported for th<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Amgen Posts Medical Education and Foundation Grants and Donations]]></title>
<link>http://www.worldpharmanews.net/Corporate/Amgen_Posts_Medical_Education_and_Foundation_Grants_and_Donations/</link>
<comments>http://www.worldpharmanews.net/Corporate/Amgen_Posts_Medical_Education_and_Foundation_Grants_and_Donations/</comments>
<pubDate>Wed, 28 May 2008 01:16:30 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Amgen_Posts_Medical_Education_and_Foundation_Grants_and_Donations/</guid>
<description><![CDATA[Amgen (NASDAQ: AMGN) posted to the company's Web site grants and donations made by the Amgen Medical Education department (AmgenMED) and the Amgen Foundation. The posting is the latest element of Cl<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[FivePrime and Pfizer Enter Oncology and Diabetes Collaboration]]></title>
<link>http://www.worldpharmanews.net/Corporate/FivePrime_and_Pfizer_Enter_Oncology_and_Diabetes_Collaboration/</link>
<comments>http://www.worldpharmanews.net/Corporate/FivePrime_and_Pfizer_Enter_Oncology_and_Diabetes_Collaboration/</comments>
<pubDate>Thu, 22 May 2008 01:02:51 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/FivePrime_and_Pfizer_Enter_Oncology_and_Diabetes_Collaboration/</guid>
<description><![CDATA[Five Prime Therapeutics, Inc. and Pfizer Inc. (NYSE:PFE) today announced the initiation of a worldwide collaborative research and license agreement. The collaboration will focus on the discovery of a<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfiser's List of Grants and Charitable Contributions]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfisers_List_of_Grants_and_Charitable_Contributions/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfisers_List_of_Grants_and_Charitable_Contributions/</comments>
<pubDate>Fri, 16 May 2008 01:03:33 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfisers_List_of_Grants_and_Charitable_Contributions/</guid>
<description><![CDATA[Pfizer announced that it has posted a list of U.S. medical, scientific and patient organization grants and charitable contributions made in the first quarter of this year, part of an ongoing drive th<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novo Nordisk researchers nominated for Europe's top innovation prize]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_researchers_nominated_for_Europes_top_innovation_prize/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_researchers_nominated_for_Europes_top_innovation_prize/</comments>
<pubDate>Tue, 06 May 2008 01:10:08 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novo_Nordisk_researchers_nominated_for_Europes_top_innovation_prize/</guid>
<description><![CDATA[A team of researchers from Novo Nordisk is nominated for Europe's top innovation prize, Inventor of the Year 2008 Award, that will be presented at a ceremony in Ljubljana, Slovenia, on 6 May by the <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Big Pharma and Biotech Assail US Patent Laws :]]></title>
<link>http://www.worldpharmanews.net/Corporate/Big_Pharma_and_Biotech_Assail_US_Patent_Laws_/</link>
<comments>http://www.worldpharmanews.net/Corporate/Big_Pharma_and_Biotech_Assail_US_Patent_Laws_/</comments>
<pubDate>Sun, 04 May 2008 22:09:40 EEST</pubDate>
<dc:creator>cliffmz</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Big_Pharma_and_Biotech_Assail_US_Patent_Laws_/</guid>
<description><![CDATA[Brand name pharmaceutical and biotechnology companies have been quietly spending millions to lobby Congress for changes in US patent law. Specifically, these companies want to overhaul the intellectu<br/><br/>2 Vote(s) ]]></description>
</item>

</channel>
</rss>
